191 related articles for article (PubMed ID: 16565092)
1. HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells.
Burdick MM; Chu JT; Godar S; Sackstein R
J Biol Chem; 2006 May; 281(20):13899-905. PubMed ID: 16565092
[TBL] [Abstract][Full Text] [Related]
2. CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity.
Hanley WD; Burdick MM; Konstantopoulos K; Sackstein R
Cancer Res; 2005 Jul; 65(13):5812-7. PubMed ID: 15994957
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow.
Thomas SN; Zhu F; Schnaar RL; Alves CS; Konstantopoulos K
J Biol Chem; 2008 Jun; 283(23):15647-55. PubMed ID: 18375392
[TBL] [Abstract][Full Text] [Related]
4. differential L-selectin binding activities of human hematopoietic cell L-selectin ligands, HCELL and PSGL-1.
Dimitroff CJ; Lee JY; Schor KS; Sandmaier BM; Sackstein R
J Biol Chem; 2001 Dec; 276(50):47623-31. PubMed ID: 11591704
[TBL] [Abstract][Full Text] [Related]
5. Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44v and alternative sialofucosylated selectin ligands.
Napier SL; Healy ZR; Schnaar RL; Konstantopoulos K
J Biol Chem; 2007 Feb; 282(6):3433-41. PubMed ID: 17135256
[TBL] [Abstract][Full Text] [Related]
6. The dual role of CD44 as a functional P-selectin ligand and fibrin receptor in colon carcinoma cell adhesion.
Alves CS; Burdick MM; Thomas SN; Pawar P; Konstantopoulos K
Am J Physiol Cell Physiol; 2008 Apr; 294(4):C907-16. PubMed ID: 18234849
[TBL] [Abstract][Full Text] [Related]
7. Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells.
Hanley WD; Napier SL; Burdick MM; Schnaar RL; Sackstein R; Konstantopoulos K
FASEB J; 2006 Feb; 20(2):337-9. PubMed ID: 16352650
[TBL] [Abstract][Full Text] [Related]
8. A Glycovariant of Human CD44 is Characteristically Expressed on Human Mesenchymal Stem Cells.
Pachón-Peña G; Donnelly C; Ruiz-Cañada C; Katz A; Fernández-Veledo S; Vendrell J; Sackstein R
Stem Cells; 2017 Apr; 35(4):1080-1092. PubMed ID: 27888602
[TBL] [Abstract][Full Text] [Related]
9. Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells.
Thomas SN; Schnaar RL; Konstantopoulos K
Am J Physiol Cell Physiol; 2009 Mar; 296(3):C505-13. PubMed ID: 19118161
[TBL] [Abstract][Full Text] [Related]
10. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
[TBL] [Abstract][Full Text] [Related]
11. Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells.
Merzaban JS; Burdick MM; Gadhoum SZ; Dagia NM; Chu JT; Fuhlbrigge RC; Sackstein R
Blood; 2011 Aug; 118(7):1774-83. PubMed ID: 21659548
[TBL] [Abstract][Full Text] [Related]
12. The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives.
Sackstein R
Curr Opin Hematol; 2011 Jul; 18(4):239-48. PubMed ID: 21546828
[TBL] [Abstract][Full Text] [Related]
13. Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells.
Thankamony SP; Sackstein R
Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2258-63. PubMed ID: 21257905
[TBL] [Abstract][Full Text] [Related]
14. The effect of soluble E-selectin on tumor progression and metastasis.
Kang SA; Blache CA; Bajana S; Hasan N; Kamal M; Morita Y; Gupta V; Tsolmon B; Suh KS; Gorenstein DG; Razaq W; Rui H; Tanaka T
BMC Cancer; 2016 May; 16():331. PubMed ID: 27220365
[TBL] [Abstract][Full Text] [Related]
15. Ligation of the CD44 Glycoform HCELL on Culture-Expanded Human Monocyte-Derived Dendritic Cells Programs Transendothelial Migration.
Videira PA; Silva M; Martin KC; Sackstein R
J Immunol; 2018 Aug; 201(3):1030-1043. PubMed ID: 29941663
[TBL] [Abstract][Full Text] [Related]
16. Glycoengineering of HCELL, the human bone marrow homing receptor: sweetly programming cell migration.
Sackstein R
Ann Biomed Eng; 2012 Apr; 40(4):766-76. PubMed ID: 22068886
[TBL] [Abstract][Full Text] [Related]
17. Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration.
Sackstein R
Immunol Rev; 2009 Jul; 230(1):51-74. PubMed ID: 19594629
[TBL] [Abstract][Full Text] [Related]
18. Fulfilling Koch's postulates in glycoscience: HCELL, GPS and translational glycobiology.
Sackstein R
Glycobiology; 2016 Jun; 26(6):560-70. PubMed ID: 26933169
[TBL] [Abstract][Full Text] [Related]
19. L-selectin-mediated lymphocyte-cancer cell interactions under low fluid shear conditions.
Resto VA; Burdick MM; Dagia NM; McCammon SD; Fennewald SM; Sackstein R
J Biol Chem; 2008 Jun; 283(23):15816-24. PubMed ID: 18385135
[TBL] [Abstract][Full Text] [Related]
20. CD44 and HCELL: preventing hematogenous metastasis at step 1.
Jacobs PP; Sackstein R
FEBS Lett; 2011 Oct; 585(20):3148-58. PubMed ID: 21827751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
